Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by baystock1on Nov 23, 2019 3:25pm

139 Views

Post# 30385696

RE:RE:RE:Another GBM trial using ALA...

Looks like they have a leg up compared to TLT in terms of funding sources. How come TLT can't get a foundation to fund their clinical costs ?

https://sonalasense.com/about-us/investors/

SonALAsense is funded entirely by angel investors, including the leadership team. We are grateful to the Ivy Foundation and the Ivy Brain Tumor Center for funding all clinical costs associated with the planned Phase 0/2 clinical study. We are moving forward directly to our first clinical trial at the Ivy Brain Tumor Center with confidence for the following reasons

Bullboard Posts

FE Battery Metals begins 2024 winter drill program